Ibrutinib inhibits antibody dependent cellular cytotoxicity induced by rituximab or obinutuzumab in MCL cell lines, not overcome by addition of lenalidomide

by Alexandra Albertsson-Lindblad, Catja Freiburghaus, Mats Jerkeman, Sara Ek
Published 2019-08-01

Nuclear T-STAR protein expression correlates with HER2 status, hormone receptor negativity and prolonged recurrence free survival in primary breast cancer and decreased cancer cell...

by Sandra Sernbo, Carl A K Borrebaeck, Mathias Uhlén, Karin Jirström, Sara Ek
Published 2013-01-01

Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk

by Lavanya Lokhande, Venera Kuci Emruli, Arne Kolstad, Martin Hutchings, Riikka Räty, Mats Jerkeman, Sara Ek
Published 2020-12-01

Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity

by Catja Freiburghaus, Venera Kuci Emruli, Angelica Johansson, Christian Winther Eskelund, Kirsten Grønbæk, Roger Olsson, Fredrik Ek, Mats Jerkeman, Sara Ek
Published 2018-04-01